Lee Alexander Grant

Royal Free London NHS Foundation Trust

Papers

1

Total Citations

21

H-Index

1

About

Lee Alexander Grant is a clinical researcher whose work centers on the surgical management of kidney cancer, with a particular focus on nephron-sparing treatments for small renal masses (SRMs). His major contribution lies in challenging the paradigm of surgical overtreatment for SRMs, which account for two-thirds of new kidney cancer diagnoses and are often indolent. Grant’s most cited work, the protocol for the NEST (Nephron Sparing Treatment) feasibility study (2019, 21 citations), pioneers a cohort-embedded randomized controlled trial design to compare active surveillance, ablation, and partial nephrectomy. This innovative methodology addresses the critical health burden of overtreatment while preserving renal function. His research is notable for integrating pragmatic trial designs into urological oncology, directly informing clinical equipoise and patient-centered decision-making. By systematically evaluating the natural history and outcomes of SRMs, Grant’s work has significant implications for reducing unnecessary surgical interventions. His contributions are essential for students and researchers interested in evidence-based de-escalation of cancer care, comparative effectiveness research, and the intersection of clinical trial methodology with real-world urological practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing <b>NE</b>phron <b>S</b>paring <b>T</b>reatment (NEST) for small renal masses
21 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Royal Free London NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago